Montis Financial’s iShares Biotechnology ETF IBB Stock Holding History

Montis Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,576	Closed	-$204K	–	65
2023 Q1	$204K	Hold	1,576	–	–	0.16%	59
2022 Q4	$207K	Buy	+1,576	New	+$204K	0.18%	59
2022 Q2	–	Sell	-1,576	Closed	-$205K	–	65
2022 Q1	$205K	Buy	+1,576	New	+$205K	0.16%	65

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Montis Financial's IBB Position: Q2 2023 in Review

Montis Financial sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 1,576 shares — an estimated $204K sold.

Montis Financial first reported a position in IBB in Q1 2022 and held it in 3 quarters. The position peaked at $207K in Q4 2022. 843 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

Montis Financial reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
Montis Financial sold 1,576 iShares Biotechnology ETF shares in Q2 2023, an estimated $204K.
Montis Financial first reported a position in iShares Biotechnology ETF in Q1 2022 and held it in 3 quarters.
Montis Financial's iShares Biotechnology ETF position peaked at $207K in Q4 2022.
843 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Montis Financial's 13F filing for Q2 2023, filed 31 Jul 2023.